Physician profile
Jeffrey Bell
NPI 1841797529
$462.55
in general payments reported to CMS, 2019-2025
12 companies · $169 in 2025
The $169 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $42.88 · 2022: $124 · 2023: $13.32 · 2024: $114 · 2025: $169.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $296.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $295.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $124.17 | 2022-2024 | |
| Jazz Pharmaceuticals INC. | $59.95 | 2025 | |
| Sumitomo Pharma America, INC. | $52.62 | 2024 | Gemtesa |
| Pfizer INC. | $44.99 | 2024 | |
| Tactile Systems Technology INC | $36.79 | 2025 | Flexitouch Plus, Nimbl |
| Abiomed | $30.57 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $24.24 | 2025 | Takhzyro |
| Merck Sharp & Dohme LLC | $22.55 | 2019 | |
| Sanofi-Aventis U.S. LLC | $20.33 | 2019 | |
| Exact Sciences Corporation | $17.10 | 2025 | Cologuard Collection Kit |
| Lilly USA, LLC | $15.92 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.32 | 2023 | Xifaxan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Bell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.